© Oxford University Press 2006.
NEWS |
FDA Revamps Committee Conflict-of-Interest Rules
| The first 150 words of the full text of this article appear below. |
The U.S. Food and Drug Administration is overhauling the process for vetting conflict of interest among its advisory committee members, an effort that has been widely called for but is unlikely to assuage most of the agency's critics.
In July, the FDA revealed plans to create new guidelines overseeing conflict of interest among its advisory committee members and outlining when the agency can grant waivers. The policies were last updated in 2000.
"There have been changes in the marketplace and in people's work that have happened since then, and there have also been changes in our thinking as an agency," FDA Deputy Commissioner Scott Gottlieb, M.D., said during a forum on conflict of interest held the same day the revisions were announced. "And so we're going to ask a lot of hard questions about whether or not certain relationships should still even require a waiver and whether or not
Internal and External Conflicts
Too Cozy With Industry?